Veeva Announces MyVeeva to Enable Patient-Centric Clinical Trials
New Analytics Platform Maps Major COVID-19 Activities in Science, Tech, and Medicine
Master the Science of Success
Welcome to the new look and branding of Pharmaceutical Executive-reimagined to better reflect you, our audience, and expand on the content you've long trusted us to deliver.
Bayer Partners with Canada's PHRI to Evaluate COVID-19 Treatments
Biofourmis Expands into Oncology Market with Acquisition of Gaido Health
Majority of HCPs Anxious About Patients’ Long-Term Care During COVID-19
Veeva’s Digital Roadmap for Field Teams
Welsh Life Sciences Hub Calls for Industry Collaboration to Fight COVID-19
Saama Makes Analytics Platform Available to Organizations Investigating COVID-19 Treatments
COVID-19 and Medical Affairs
AstraZeneca Teams Up with BrightInsight
COVID-19: Tanner Pharma Group Announces Leukine Emergency Access Program
“Time to Flip the Digital Switch:” COVID-19 and Pharma Sales
ZS offers advice to ensure reps can stay engaged with their customers during these times of changing needs and constraints.
COVID-19 Upends Business-as-usual Research and Regulatory Practices
Now officially a worldwide pandemic, the biomedical research community is rushing to develop treatments and preventives to halt the spread and severity of the COVID-19 virus.
MassBio and Bayer Partner to Support Startup Community
Veeva Offers Back-Up Plan for Coronavirus-Impacted Life Sciences Companies
Pharmaceutical Executive, March 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.
How to Successfully Mitigate Risk and Dissatisfaction in Patient Service Programs
High customer satisfaction and low risk is the goal for patient service programs and is possible with focus on solid service delivery and quality.
European Pharma's Response to Coronavirus Crisis
2020 and Beyond Will Bring Significant Progress in Addressing Mental Illness
Progress has been made in developing new approaches for patients with serious mental health conditions.
MassBio Launches New Mentoring Program
Signals Analytics Expands Rare Disease Data Coverage
Virus Spread Threatens Pharmaceutical Supplies, Clinical Research
The continued COVID-19 outbreak has fueled fears of drug shortages, primarily for active pharmaceutical ingredients produced in China.
Bayer and Nuvisan Create New Research Unit in Berlin
Eversana Reveals New Portfolio of Consulting Services
Becoming a Pharma Industry Leader
With the nomination period for our latest Emerging Pharma Leaders selections in full swing, it's a good reminder that the industry's future path ultimately depends on its leaders, emerging and otherwise.
Market Access: From Being to Becoming
Key learnings from the BCG Market Access benchmark 2019.
Fingerpaint Acquires Managed Markets Firm 1798
Pharmaceutical Executive, February 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.
Country Report: Hungary
Hungary is fast staking a reputation for itself as one of Central and Eastern Europe’s most dynamic economies. A major factor has been pharmaceuticals, where Hungary’s history of research and production is reflected today in an attractive pharma investment landscape and the presence of home-grown success stories.
